These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 11312711)

  • 1. Comparison of different bioreactor systems for the production of high titer retroviral vectors.
    Merten OW; Cruz PE; Rochette C; Geny-Fiamma C; Bouquet C; Gonçalves D; Danos O; Carrondo MJ
    Biotechnol Prog; 2001; 17(2):326-35. PubMed ID: 11312711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retroviral vector production using suspension-adapted 293GPG cells in a 3L acoustic filter-based perfusion bioreactor.
    Ghani K; Garnier A; Coelho H; Transfiguracion J; Trudel P; Kamen A
    Biotechnol Bioeng; 2006 Nov; 95(4):653-60. PubMed ID: 16947907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of culture parameters on the production of retroviral vectors by a human packaging cell line.
    McTaggart S; Al-Rubeai M
    Biotechnol Prog; 2000; 16(5):859-65. PubMed ID: 11027182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of retrovirus and adenovirus vectors for gene therapy: a comparative study using microcarrier and stationary cell culture.
    Wu SC; Huang GY; Liu JH
    Biotechnol Prog; 2002; 18(3):617-22. PubMed ID: 12052081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental and modelling study of different process modes for retroviral production in a fixed bed reactor.
    Nehring D; Gonzalez R; Pörtner R; Czermak P
    J Biotechnol; 2006 Mar; 122(2):239-53. PubMed ID: 16298006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Closed hollow-fiber bioreactor: a new approach to retroviral vector production.
    Pan D; Whitley CB
    J Gene Med; 1999; 1(6):433-40. PubMed ID: 10753069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of retroviral packaging and producer cell lines for large-scale vector production and clinical application: improved safety and high titer.
    Sheridan PL; Bodner M; Lynn A; Phuong TK; DePolo NJ; de la Vega DJ; O'Dea J; Nguyen K; McCormack JE; Driver DA; Townsend K; Ibañez CE; Sajjadi NC; Greengard JS; Moore MD; Respess J; Chang SM; Dubensky TW; Jolly DJ; Sauter SL
    Mol Ther; 2000 Sep; 2(3):262-75. PubMed ID: 10985957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of retroviral vectors for gene therapy with the human packaging cell line FLYRD18.
    Gerin PA; Searle PF; Al-Rubeai M
    Biotechnol Prog; 1999; 15(5):941-8. PubMed ID: 10514266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of a high-titer packaging cell line for the production of retroviral vectors in suspension and serum-free media.
    Ghani K; Cottin S; Kamen A; Caruso M
    Gene Ther; 2007 Dec; 14(24):1705-11. PubMed ID: 17928873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. State-of-the-art of the production of retroviral vectors.
    Merten OW
    J Gene Med; 2004 Feb; 6 Suppl 1():S105-24. PubMed ID: 14978755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upflow anaerobic sludge blanket reactor--a review.
    Bal AS; Dhagat NN
    Indian J Environ Health; 2001 Apr; 43(2):1-82. PubMed ID: 12397675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retroviral vector production under serum deprivation: The role of lipids.
    Rodrigues AF; Carmo M; Alves PM; Coroadinha AS
    Biotechnol Bioeng; 2009 Dec; 104(6):1171-81. PubMed ID: 19655394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of a retroviral vector production system with the minimum possibility of a homologous recombination.
    Yu SS; Han E; Hong Y; Lee JT; Kim S; Kim S
    Gene Ther; 2003 Apr; 10(8):706-11. PubMed ID: 12692599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large-scale manufacturing of safe and efficient retrovirus packaging lines for use in immunotherapy protocols.
    Farson D; McGuinness R; Dull T; Limoli K; Lazar R; Jalali S; Reddy S; Pennathur-Das R; Broad D; Finer M
    J Gene Med; 1999; 1(3):195-209. PubMed ID: 10738568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-scale clinical-grade retroviral vector production in a fixed-bed bioreactor.
    Wang X; Olszewska M; Qu J; Wasielewska T; Bartido S; Hermetet G; Sadelain M; Rivière I
    J Immunother; 2015 Apr; 38(3):127-35. PubMed ID: 25751502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving adeno-associated vector yield in high density insect cell cultures.
    Mena JA; Aucoin MG; Montes J; Chahal PS; Kamen AA
    J Gene Med; 2010 Feb; 12(2):157-67. PubMed ID: 20101623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of recombinant adeno-associated viral vectors using a baculovirus/insect cell suspension culture system: from shake flasks to a 20-L bioreactor.
    Meghrous J; Aucoin MG; Jacob D; Chahal PS; Arcand N; Kamen AA
    Biotechnol Prog; 2005; 21(1):154-60. PubMed ID: 15903253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a scalable process for high-yield lentiviral vector production by transient transfection of HEK293 suspension cultures.
    Ansorge S; Lanthier S; Transfiguracion J; Durocher Y; Henry O; Kamen A
    J Gene Med; 2009 Oct; 11(10):868-76. PubMed ID: 19618482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of a mink enteritis vaccine production process in stirred-tank reactor and Wave Bioreactor microcarrier culture in 1-10 L scale.
    Hundt B; Best C; Schlawin N; Kassner H; Genzel Y; Reichl U
    Vaccine; 2007 May; 25(20):3987-95. PubMed ID: 17391818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimized conditions for the production of recombinant amphotropic retroviral vector preparations.
    Kaptein LC; Greijer AE; Valerio D; van Beusechem VW
    Gene Ther; 1997 Feb; 4(2):172-6. PubMed ID: 9081708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.